Man Group’s Medtronic MDT Stock Holding History

Man Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,100	Closed	-$1.25M	–	2285
2021 Q4	$1.25M	Buy	+12,100	New	+$1.4M	﹤0.01%	1278

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Man Group's MDT Position: Q2 2026 in Review

Man Group increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $6.88M and bringing the position to 416,155 shares worth $32.6M. The position accounts for 0.05% of the portfolio, ranked #364.

Man Group first reported a position in MDT in Q1 2018 and has held it in 31 quarters since. The position peaked at $216M in Q3 2018. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Man Group held 416,155 shares of Medtronic worth $32.6M as of Q2 2026.
Man Group bought 85,266 Medtronic shares in Q2 2026, an estimated $6.88M.
Medtronic made up 0.05% of Man Group's portfolio in Q2 2026, its #364 holding.
Man Group first reported a position in Medtronic in Q1 2018 and has held it in 31 quarters since.
Man Group's Medtronic position peaked at $216M in Q3 2018.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.